Date Filed | Type | Description |
02/13/2017 |
SC 13G/A
| Henriques Charles A. reports a 15% stake in NeurogesX, Inc. |
02/09/2017 |
SC 13G/A
| KCG AMERICAS LLC reports a 5.1% stake in NeurogesX, Inc.     |
02/17/2016 |
SC 13G/A
| Henriques Charles A. reports a 13.8% stake in NeurogesX, Inc. |
07/11/2013 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp... |
06/24/2013 |
8-K
| Quarterly results |
04/17/2013 |
8-K
| Acquisition/merger/asset purchase announced |
03/27/2013 |
8-K
|
SEC Filing in the EDGAR database
|
03/27/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
03/27/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
03/27/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
03/27/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
03/25/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
03/25/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
03/25/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
03/25/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
03/11/2013 |
8-K
| Entry into a Material Definitive Agreement, Other Events |
03/05/2013 |
8-K
| Cost Associated with Exit or Disposal Activities, Other Events |
01/08/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/04/2012 |
4
| Ghiglieri Stephen F (Exec. V.P., COO & CFO) has filed a Form 4 on NeurogesX Inc |
11/30/2012 |
8-K
| Cost Associated with Exit or Disposal Activities, Other Events |
11/14/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
11/14/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
09/19/2012 |
4/A
| Markels Michael (Senior VP,Commercial & Bus Dev) has filed a Form 4 on NeurogesX Inc |
09/14/2012 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
09/14/2012 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
09/05/2012 |
4
| Markels Michael (Senior VP,Commercial & Bus Dev) has filed a Form 4 on NeurogesX Inc |
09/05/2012 |
4
| Ghiglieri Stephen F (Exec. V.P., COO & CFO) has filed a Form 4 on NeurogesX Inc |
08/30/2012 |
GN
| NeurogesX' NGX-1998 Well-Tolerated Treatment Demonstrated Clear Dose-Response in Patients |
08/24/2012 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
08/10/2012 |
10-Q
| Quarterly Report for the period ended June 30, 2012 |
08/07/2012 |
4
| Markels Michael (Senior VP,Commercial & Bus Dev) has filed a Form 4 on NeurogesX Inc |
08/07/2012 |
4
| Ghiglieri Stephen F (Exec. V.P., COO & CFO) has filed a Form 4 on NeurogesX Inc |
08/07/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
|